Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-06-2009 | Rhinology

Nasopharyngeal carcinoma: our experience

Authors: Carla d’Espiney Amaro, Pedro Montalvão, Pedro Henriques, Miguel Magalhães, João Olias

Published in: European Archives of Oto-Rhino-Laryngology | Issue 6/2009

Abstract

The objectives of our study were to characterize nasopharyngeal carcinoma patients in the Portuguese Institute of Oncology Hospital in Lisbon (IPOLFG) and identify the main factors that interfere with patients survival rate. We performed a retrospective study involving 157 patients (65% male and 35% female) between the years 2000 and 2005, and a histological classification according to Health World Organization. We constructed a Kaplan–Meier survival curve for the studied patients and evaluated the significance of the different studied factors with a Pearson correlation study. With an average age of 53 years, most of the carcinomas were type III (58%), followed by type II (30%) and at last type I (8%). Fifty-one of carcinomas were in stage IV at time of diagnosis. Ninety-five patients (60%) had remission. Five-year actuarial survival rate of all patients was 65.1%. There was a significant difference (P = 0.033) in the actuarial survival rate of staged IV patients treated with adjuvant chemotherapy. Undifferentiated nasopharyngeal carcinoma is the most frequent type in our geographic area. Chemotherapy improves survival rate, mainly in late stages.

Boussen H, Bouaoina N, Gamoudi A, Moukni N et al (2007) Cancers du nasopharynx. In: Encyclopédie Médico-Chirurgicale. 2007, 20-590-A-10

Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765–1777. doi:10.1158/1055-9965.EPI-06-0353 PubMedCrossRef

Jiong L, Berrino F, Coebergh J (1998) Eurocare working group. Variation in survival for adults with nasopharyngeal cancer in Europe, 1978–1989. Eur J Cancer 34:2162–2166. doi:10.1016/S0959-8049(98)00322-0 CrossRef

Nichols J, Agathanggelou A, Fung K, Xiangguo Z et al (1997) The association of squamous cell carcinomas of the nasopharynx with Epstein–Barr virus shows geographical variation reminiscent of Burkitt’s lymphoma. J Pathol 183(2):164–168. doi:10.1002/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-JCrossRef

Pegtel D, Subramanian A, Meritt D, Tsai C et al (2007) IFN-α-syimulated genes and Epstein–Barr virus gene expression distinguish WHO type II and type III nasopharyngeal carcinomas. Cancer Res 67(2):474–481. doi:10.1158/0008-5472.CAN-06-1882 PubMedCrossRef

Punwaney R, Brandwein M, Zhang D, Urken M et al (1999) Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein–Barr virus and human papillomavirus in Eastern and Western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck 21(1):21–29. doi:10.1002/(SICI)1097-0347(199901)21:1<21::AID-HED3>3.0.CO;2-ZPubMedCrossRef

Marks J, Phillips J, Menck H (1998) The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582–588. doi:10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-RPubMedCrossRef

Sun L, Li C, Huang E, Vaughan T (2007) Survival differences by race in nasopharyngeal carcinoma. Am J Epidemiol 165:271–278. doi:10.1093/aje/kwk008 PubMedCrossRef

Vaughan T, Shapiro J, Burt R, Swason G et al (1996) Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 5:587–593PubMed

10.

Ou S, Zell J, Ziogas A, Anton-Culver H (2007) Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 18:29–35. doi:10.1093/annonc/mdl320 PubMedCrossRef

11.

Klemenc P, Marin J, Soba E, Gale N et al (2006) Distribution of Epstein–Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. J Med Virol 78(8):1083–1090. doi:10.1002/jmv.20666 PubMedCrossRef

12.

Plaza G, Manzanal A, Fougué L, Santón A et al (2002) Association of Epstein–Barr virus and nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol 111:210–216PubMed

13.

Pai P, Tseng C, Chuang C, Wei K et al (2007) Polymorphism of C-terminal activation region 2 of Epstein–Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. Head Neck 29(2):109–119. doi:10.1002/hed.20483 PubMedCrossRef

14.

Zhou G, Zhai Y, Cui Y, Zhang X et al (2007) MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 13(9):2627–2633. doi:10.1158/1078-0432.CCR-06-2281 PubMedCrossRef

15.

Chen S, Liang S, Zheng W et al (2008) Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanisms of EBV-regulated neoplastic transformation. BMC Genomics 9:322. doi:10.1186/1471-2164-9-322 PubMedCrossRef

16.

Fachiroh J, Schouten T, Hariwiyanto B, Paramita D et al (2004) Molecular diversity of Epstein–Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese and European subjects. J Infect Dis 190(1):53–62. doi:10.1086/421245 PubMedCrossRef

17.

Pratesi C, Bortolin M, D’Andrea M, Vaccher E et al (2003) Quantitive plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients. J Clin Virol 28(2):155–164. doi:10.1016/S1386-6532(02)00276-7 PubMedCrossRef

18.

Twu C, Wang W, Liang W, Jan J et al (2007) Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67(1):130–137. doi:10.1016/j.ijrobp.2006.07.012 PubMed

19.

Farrow D, Vaughan T, Berwick M, Lynch C et al (1998) Diet and nasopharyngeal cancer in a low-risk population. Int J Cancer 78(6):675–679. doi:10.1002/(SICI)1097-0215(19981209)78:6<675::AID-IJC2>3.0.CO;2-JPubMedCrossRef

20.

Chan ATC, Teo PML, Johnson PJ (2002) Nasopharyngeal carcinoma. Ann Oncol 13:1007–1015. doi:10.1093/annonc/mdf179 PubMedCrossRef

21.

Ma BBY, Hui EP, Chan ATC (2008) Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci 99:1311–1319. doi:10.1111/j.1349-7006.2008.00836.x PubMedCrossRef

22.

Friborg J, Yuan J, Wang R, Koh W et al (2007) A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese. Cancer 109(6):1183–1191. doi:10.1002/cncr.22501 PubMedCrossRef

23.

Gregoire V, Levendag P et al (2003) CT-based delineation of lymph node levels and related clinical target volume in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227–236. doi:10.1016/j.radonc.2003.09.011 PubMedCrossRef

24.

Breda E, Catarino R, Azevedo I, Fernandes T et al (2007) Characterization of the clinical evolution of nasopharyngeal carcinoma in a Portuguese population. Acta Otorrinolaringol Esp 58(5):191–197PubMedCrossRef

25.

Mendenhall W, Christopher M, Hinerman R, Malyapa R et al (2006) Definitive radiotherapy for nasopharyngeal carcinoma. Am J Clin Oncol 29(6):622–627. doi:10.1097/01.coc.0000248895.90193.7e PubMedCrossRef

26.

Kristensen C, Kjaer-kristoffersen F, Sapru W, Berthelsen A et al (2007) Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncol 46(2):214–220. doi:10.1080/02841860600635862 PubMedCrossRef

27.

Huang C, Huang S, Lee T, Ng S et al (2007) Postirradiation sinus mucosa disease in nasopharyngeal carcinoma patients. Laryngoscope 117(4):737–742. doi:10.1097/MLG.0b013e3180325b6c PubMedCrossRef

28.

Ku P, Yuen E, Cheung D, Chan B et al (2007) Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: symptomatology and videofluoroscopic findings. Laryngoscope 117(1):142–146. doi:10.1097/01.mlg.0000248738.55387.44 PubMedCrossRef

29.

King AD, Ahuja AT, Yeung DK et al (2007) Delayed complications of radiotherapy treatment of nasopharyngeal carcinoma: imaging findings. Clin Radiol 62:195–203. doi:10.1016/j.crad.2006.10.011 PubMedCrossRef

30.

Kong L, Lu J, Hu C, Guo X et al (2006) The risk of second primary tumours in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer 107(6):1287–1293. doi:10.1002/cncr.22119 PubMedCrossRef

31.

Ozyar E, Selek U, Laskar S, Uzel O et al (2006) Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a rare cancer network study. Radiother Oncol 81(1):39–46. doi:10.1016/j.radonc.2006.08.019 PubMedCrossRef

32.

Wei WI, Mok V (2007) The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15:99–102. doi:10.1097/MOO.0b013e3280148a06 PubMedCrossRef

Title: Nasopharyngeal carcinoma: our experience
Authors: Carla d’Espiney Amaro
Pedro Montalvão
Pedro Henriques
Miguel Magalhães
João Olias
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: European Archives of Oto-Rhino-Laryngology / Issue 6/2009
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-008-0822-6

At a glance: The STEP trials

Springer Medicine

Nasopharyngeal carcinoma: our experience

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

The growth rate and size of the mastoid air cell system and mastoid bone: a review and reference

Additional use of acupuncture to NSAID effectively reduces post-tonsillectomy pain

Medial fracturing of the inferior turbinate: effect on the ostiomeatal unit and the uncinate process

Self-reported disability and handicap after hearing-aid fitting and benefit of hearing aids: comparison of fitting procedures, degree of hearing loss, experience with hearing aids and uni- and bilateral fittings

Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study

Ophthalmic disturbances in children with sensorineural hearing loss